Trials / Completed
CompletedNCT03693001
HBOT for Patients With IC/FM (Interstitial Cystitis/Fibromyalgia)
Clinical and Morphological Effects of Hyperbaric Oxygen Therapy in Patients With Interstitial Cystitis Associated With Fibromyalgia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators observed 12 fibromyalgia and interstitial cystitis patients undergoing hyperbaric oxygen oxygen treatment in a multiplace pressure chamber for 90 minutes, 40 treatment each, using an oro-nasal mask.
Detailed description
The investigators structured a prospective observational pilot experimental design in consenting patients with IC and FM, with repeated subjective and urological measures conducted before and after a therapeutic protocol. The study duration was set to 3 months. Patients were exposed to breathing 100% oxygen at 2 atmospheres absolute (ATA) in a multiplace pressure chamber for 90 minutes using an oro-nasal mask. Patients undertook a cycle of 20 sessions for 5 days per week for four weeks. After one week of suspension, a second cycle of 20 sessions was completed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intermittent Exposure to Oxygen via Oro-Nasal Mask | Patients were exposed to breathing 100% oxygen at 2 atmospheres absolute (ATA) in a multiplace pressure chamber for 90 minutes using an oro-nasal mask for 40 treatments over a 2 month period. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-15
- First posted
- 2018-10-02
- Last updated
- 2020-12-09
Source: ClinicalTrials.gov record NCT03693001. Inclusion in this directory is not an endorsement.